Cargando…
Protocol for rheumatoid arthritis complicated with cardiovascular damage treated with Guanxining tablet with a randomized controlled trial
BACKGROUND: Cardiovascular disease (CVD) is the main cause of death in patients with rheumatoid arthritis (RA). Apart from traditional cardiovascular risk factors, immune dysfunction and chronic inflammation of RA are also risk factors for complex cardiovascular damage. Although methotrexate (MTX) i...
Autores principales: | Yu, Kai, Yang, Kepeng, Han, Tingfen, Sun, Qice, Zhu, Ming, Wang, Xinchang, Wang, Weijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474432/ https://www.ncbi.nlm.nih.gov/pubmed/37662776 http://dx.doi.org/10.1016/j.heliyon.2023.e19241 |
Ejemplares similares
-
Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: Network pharmacology and molecular docking analysis
por: Niu, Chaofeng, et al.
Publicado: (2023) -
Network Pharmacology-Based Approach Uncovers the Mechanism of GuanXinNing Tablet for Treating Thrombus by MAPKs Signal Pathway
por: Wang, Mu-Lan, et al.
Publicado: (2020) -
Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish
por: Li, Jun, et al.
Publicado: (2021) -
Protective effects of GuanXinNing tablet (GXNT) on diabetic encephalopathy in zucker diabetic obesity (ZDF) rats
por: Li, Yajing, et al.
Publicado: (2023) -
Rheumatoid arthritis characteristics and classification of heat and cold patterns–an observational study
por: Wang, Weijie, et al.
Publicado: (2023)